NICHOLAS FINER
Nick Finer, MBBS, FRCP, FAfN, FTOS
Former honorary Professor of Clinical Medicine and Consultant in Obesity Medicine at University College
London, UK, Nick trained as a clinical academic endocrinologist and over 3 decades developed multidisciplinary
obesity services at Guy’s, Luton, Cambridge, and University College London hospitals. From 2016-2022, Nick
was Senior Principal Clinical Scientist at Novo Nordisk in Denmark. Nick is past Chair of the UK Association for
the Study of Obesity, World Obesity Federation Clinical Care, and founding Editor-in-Chief of Clinical Obesity.
Former honorary Professor of Clinical Medicine and Consultant in Obesity Medicine at University College
London, UK, Nick trained as a clinical academic endocrinologist and over 3 decades developed multidisciplinary
obesity services at Guy’s, Luton, Cambridge, and University College London hospitals. From 2016-2022, Nick
was Senior Principal Clinical Scientist at Novo Nordisk in Denmark. Nick is past Chair of the UK Association for
the Study of Obesity, World Obesity Federation Clinical Care, and founding Editor-in-Chief of Clinical Obesity.
Check the activity agenda
Thursday, June 27, 2024
• Room 2 - John Waterlow
10:00-11:00
MINI CONFERENCE
The role of Intensive Behaviour treatment with new generation anti-obesity medications
Tryglycerides and CVD residual risk reduction: is obesity the missing link?
Coordinator: Ana Maria Pita Lottenberg (SP)
The role of Intensive Behaviour treatment with new generation anti-obesity medications
Speaker: Nicholas Finer (United Kingdom)
Tryglycerides and CVD residual risk reduction: is obesity the missing link?
Speaker: Raul Santos (SP)
16:30-18:00
WILLENDORF AND WERTHEIMER AWARD LECTURES
Teaching Ravens to Fly Underwater
The Protein Leverage Hypothesis
Moderator: Donna Ryan (United States)
Teaching Ravens to Fly Underwater
Speaker: Nicholas Finer (United Kingdom)
The Protein Leverage Hypothesis
Speaker: David Raubenheimer (Australia)
Friday, June 28, 2024
• Room 1 - Alfredo Halpern
16:30-18:00
SESSION: THE CHALLENGE OF WEIGHT MAINTENANCE
Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima
Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery
How to reduce barriers for the long term pharmacological treatment of obesity?
What do we know about successful weight maintainers?
Discussion
Coordinator: Deborah B. Horn (United States)
Coordinator: Paul Camperos (Venezuela, RB)
Abstracts - 129826: EFFECTS OF MIRABEGRON AND QUINOLONE ON THE ACTIVATION OF BROWN ADIPOSE TISSUE IN HUMANS (MIRAQL-BAT STUDY) - Presenter: Marcelo Miranda de Oliveira de Lima
Physiology of the weight loss plateau in response to lifestyle intervention, novel pharmacological therapy and bariatric surgery
Speaker: Kevin D. Hall (United States)
How to reduce barriers for the long term pharmacological treatment of obesity?
Speaker: Nicholas Finer (United Kingdom)
What do we know about successful weight maintainers?
Speaker: Cintia Cercato (SP)
Discussion
Venue
Centro de Convenções Frei Caneca
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
R. Frei Caneca, 569 - Bela Vista,
São Paulo - SP, 01307-001
website ACCOMMODATION
PROMOTED BY
MANAGEMENT
Tourism Agency
DIAMOND SPONSOR
GOLD SPONSOR
BRONZE SPONSOR
SPONSOR
